Have you been diagnosed with chronic lymphocytic leukemia (CLL)?
Your experience matters.
Share your insights to help others in the future.
We are inviting people diagnosed with chronic lymphocytic leukemia (CLL) to take part in a 60-minute online interview about their experiences and opinions. Those who qualify and complete the interview will receive a check for $175 as a thank you.
You may be eligible to participate if:
You are currently receiving Imbruvica (ibrutinib) as your first and only prescription treatment for CLL
or
You are currently receiving another BTKi therapy such as Brukinsa (zanubrutinib), Jaypirca (pirtobrutinib), or Calquence (acalabrutinib) and you previously received Imbruvica (ibrutinib) as your first prescription treatment for CLL
Participation involves:
A 15-minute screening call with a member of our team to confirm if you are eligible to participate.
Confirmation of your diagnosis and treatment (this might include a screenshot from your medical record, a letter from your healthcare provider, a photo of your prescription bottle, etc.)
A one-hour conversation with a healthcare researcher about the impacts of CLL on your life and your experiences with treatments.
Interested?
Please click the link below to answer a few quick questions. If your responses indicate that you might qualify, you will be directed to a calendar to schedule a call with the project manager. All information and insights shared will remain confidential.
All participants must be 18 or older and live in the US.
You will be asked to join our community and answer a few quick questions to help match you to opportunities you may qualify for. You can opt out at any time by emailing optout@pinpointpatientcommunity.com.